Scarring Alopecia (FFA) Clinical Trial
A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia Click HERE to learn more about this open trial.
2022 Scarring Alopecia Grant Report
Click HERE to view the report